Literature DB >> 18252763

Pathological features of temporal arteries in patients with giant cell arteritis presenting with permanent visual loss.

D Chatelain1, P Duhaut, J Schmidt, R Loire, S Bosshard, M Guernou, H Pellet, J C Piette, H Sevestre, J P Ducroix.   

Abstract

BACKGROUND: Permanent visual loss (PVL) is the most feared complication of giant cell arteritis (GCA), and its risk factors are still unclear.
OBJECTIVES: The aim of our study was to assess the pathological features predictive of PVL on temporal artery biopsy (TAB) specimens in patients with GCA.
METHODS: The slides of 391 TAB specimens from patients with GCA were reviewed by two pathologists without clinical information.
RESULTS: A total of 29 patients (26 females and 3 males, mean age 78.3 years) presented with unilateral PVL at the onset of the disease, and 362 patients (258 females, 104 males, mean age 74.7 years), did not. The pathological features strongly predictive for PVL were the presence (p = 0.003), number (p = 0.001) and aggregates of giant cells (p = 0.001), presence of plasmocytes (p = 0.002), thickened intima (p = 0.007), neoangiogenesis (p = 0.001) and degree of arterial occlusion (p = 0.006). Presence of neutrophils, eosinophils, parietal necrosis, calcification in the arterial wall and disruption of the internal elastic membrane were similar in both groups. Total obstruction of the arterial lumen by a thrombus, intensity of the inflammatory cells infiltration and inflammation of small vessels, nerves and veins surrounding the temporal artery were not associated with blindness. In multivariate analysis, only giant cells remained significantly associated with PVL.
CONCLUSION: Giant cells are strongly associated with PVL, with a significant gradient between great risk and large number of giant cells. However, PVL was neither associated with the intensity of the inflammatory infiltrate, nor with the presence of arterial thrombosis.

Entities:  

Mesh:

Year:  2008        PMID: 18252763     DOI: 10.1136/ard.2007.084947

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  16 in total

1.  Diagnosis and treatment of cerebral vasculitis.

Authors:  Peter Berlit
Journal:  Ther Adv Neurol Disord       Date:  2010-01       Impact factor: 6.570

2.  [Giant cell arteritis: etiological knowledge and diagnostic challenge for pathologists].

Authors:  S C Schaefer; H A Lehr
Journal:  Pathologe       Date:  2012-05       Impact factor: 1.011

Review 3.  Polymyalgia rheumatica and giant cell arteritis in older patients: diagnosis and pharmacological management.

Authors:  Jean Schmidt; Kenneth J Warrington
Journal:  Drugs Aging       Date:  2011-08-01       Impact factor: 3.923

4.  Varicella zoster virus ischemic optic neuropathy and subclinical temporal artery involvement.

Authors:  Richard Salazar; Andrew N Russman; Maria A Nagel; Randall J Cohrs; Ravi Mahalingam; D Scott Schmid; Bette K Kleinschmidt-DeMasters; Eve M VanEgmond; Don Gilden
Journal:  Arch Neurol       Date:  2011-04

5.  Treatment of vision loss in giant cell arteritis.

Authors:  Ryan A Scheurer; Andrew R Harrison; Michael S Lee
Journal:  Curr Treat Options Neurol       Date:  2012-02       Impact factor: 3.598

6.  Temporal arteritis.

Authors:  Andrew W Lee; Celia Chen; Sudha Cugati
Journal:  Neurol Clin Pract       Date:  2014-04

Review 7.  Visual loss and other cranial ischaemic complications in giant cell arteritis.

Authors:  Alessandra Soriano; Francesco Muratore; Nicolò Pipitone; Luigi Boiardi; Luca Cimino; Carlo Salvarani
Journal:  Nat Rev Rheumatol       Date:  2017-07-06       Impact factor: 20.543

8.  The diagnostic value of ultrasonography-derived edema of the temporal artery wall in giant cell arteritis: a second meta-analysis.

Authors:  Aikaterini Arida; Miltiades Kyprianou; Meletios Kanakis; Petros P Sfikakis
Journal:  BMC Musculoskelet Disord       Date:  2010-03-08       Impact factor: 2.362

9.  Visual Complications in Patients with Biopsy-proven Giant Cell Arteritis: A Population-based Study.

Authors:  Muna Saleh; Carl Turesson; Martin Englund; Peter A Merkel; Aladdin J Mohammad
Journal:  J Rheumatol       Date:  2016-06-01       Impact factor: 4.666

Review 10.  Recent Advances in Giant Cell Arteritis.

Authors:  M Guevara; C S Kollipara
Journal:  Curr Rheumatol Rep       Date:  2018-04-02       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.